Geron Corp. (GERN)
1.58
-0.02
(-1.25%)
USD |
NASDAQ |
Mar 13, 16:00
1.59
+0.01
(+0.63%)
After-Hours: 20:00
Geron Shareholders Equity (Quarterly) : 225.87M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 489.09M |
| Recursion Pharmaceuticals, Inc. | 1.131B |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| BioMarin Pharmaceutical, Inc. | 6.087B |
| Plus Therapeutics, Inc. | 3.996M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 571.08M |
| Total Liabilities (Quarterly) | 345.21M |
| Debt to Equity Ratio | 1.114 |
| Current Ratio | 4.664 |
| Net Debt Paydown Yield | -3.89% |